Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6197 results
  • Science & Technology
  • Health & Medicine
  • For Researchers

Why diversity in STEM is vital to cancer research

Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research… Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research…

by Cancer Research UK | Analysis | 3 March 2022

3 March 2022

This entry is part 4 of 10 in the series Diversity in research
%postcontent%
A consultation with 2 people and a doctor

The first analysis in over 10 years looking at which ethnic groups in England are more likely to get cancer has now been published by Cancer Research UK analysts.  The first analysis in over 10 years looking at which ethnic groups in England are more likely to get cancer has now been published by Cancer Research UK analysts. 

by Cancer Research UK | Analysis | 2 March 2022

2 March 2022

Seb
  • Science & Technology
  • For Researchers

Embracing a full spectrum of researchers

For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research

by Cancer Research UK | Analysis | 24 February 2022

24 February 2022

This entry is part 5 of 10 in the series Diversity in research
%postcontent%
Breast cancer exam.

Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms. Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.

by Lilly Matson | News | 22 February 2022

22 February 2022

Illustration showing inequalities.

We talk to Professor Sir Michael Marmot, who's been at the forefront of health inequality research for decades, to discuss what it is and how we can reduce it. We talk to Professor Sir Michael Marmot, who's been at the forefront of health inequality research for decades, to discuss what it is and how we can reduce it.

by Harry Jenkins | Analysis | 15 February 2022

15 February 2022

This entry is part 1 of 5 in the series Health inequalities
%postcontent%
Photograph of a person having an MRI scan.

New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways. New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways.

by Lilly Matson | Analysis | 14 February 2022

14 February 2022

Vivian Li, group leader of the stem cell and cancer biology lab at the Francis Crick Institute

Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments. Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

by Phil Prime | In depth | 11 February 2022

11 February 2022

Breast cancer tissue under the microscope.

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women. A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

by In collaboration with PA Media Group | News | 11 February 2022

11 February 2022

A photograph of a lab at the Imperial Cancer Research Fund in the 1960's.
  • Science & Technology
  • Health & Medicine

Diving into our role in 50 top cancer drugs

To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today. To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today.

by Catherine Pickworth | In depth | 9 February 2022

9 February 2022

Michelle Mitchell chief executive Cancer Research UK
  • Health & Medicine
  • Policy & Insight

Javid's war on cancer can't leave people behind

We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan. We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan.

by Michelle Mitchell | Opinion | 4 February 2022

4 February 2022